NCT05979844View on ClinicalTrials.gov

MDMA-assisted Brief Cognitive Behavioral Conjoint Therapy for PTSD

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 6, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
PTSDRelational Problems
Interventions
DRUG

3,4-methylenedioxymethamphetamine (MDMA)

2 MDMA sessions; PTSD+ Veteran partner only

BEHAVIORAL

Brief Cognitive Behavioral Conjoint Therapy (bCBCT)

8 bCBCT sessions; Both partners

Trial Locations (1)

92161

VA San Diego Healthcare System, San Diego, CA, San Diego

Sponsors
All Listed Sponsors
collaborator

Healing Breakthrough

UNKNOWN

collaborator

Lykos Therapeutics

INDUSTRY

collaborator

San Diego Veterans Healthcare System

FED

lead

Dr. Leslie Morland

FED

NCT05979844 - MDMA-assisted Brief Cognitive Behavioral Conjoint Therapy for PTSD | Biotech Hunter | Biotech Hunter